Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Blood-Thinning Drug Dangers

Ivanhoe Newswire


Related Encyclopedia
 border=
Alzheimer's Disease
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Baby Steps: Fertility Findings
Saving Memories with a Shake: The Alzheimer's Drink
Tumor Detecting App: Medicine's Next Big Thing?
Powerful Combo Reducing Lymphedema
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Cialis
Coumadin
Detrol LA
More...

Related News Articles
 border=
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
Young Women Who Drink and Drive at Higher Risk of Fatal Accident
Bacteria From Mouth Can Lead to Heart Inflammation: Study
More...

(Ivanhoe Newswire) -- A common blood-thinning drug may have deadly side effects.

A new report from the University of Cincinnati finds warfarin may cause more bleeding in the brain and increase the risk of death in patients who have a hemorrhagic stroke.

Text Continues Below



Warfarin is commonly prescribed to prevent blood clotting. Research shows it helps prevent ischemic stroke in patients with an abnormal heart rhythm called atrial fibrillation. But if the drug makes the blood too thin, it can increase the risk of brain hemorrhage, a type of stroke caused by bleeding in the brain.

Researchers looked at 258 patients who had brain hemorrhage -- 51 were taking warfarin. Participants were 69 years old on average.

The study found participants who took warfarin and suffered a brain hemorrhage while their international normalized ratio (INR) was above three had about twice as much initial bleeding as those not taking the drug. But this did not happen in patients whose blood was less likely to clot as determined by an INR of less than three. An INR test measures the ability of blood to clot.

Fortunately, we did not see larger blood clots in people with an INR of less than three, study author Matthew L. Flaherty, M.D., University of Cincinnati, was quoted as saying. For most patients on warfarin, the goal INR is between two and three. This shows the importance of good monitoring and adjustment of warfarin dose. People should talk to their doctors about the proper management of warfarin and learn the signs of stroke so they can get to an emergency room immediately if a stroke occurs.

SOURCE: Neurology, 2008;71:1084

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Lindsay Braun at lbraun@ivanhoe.com.

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 9/30/2008

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire